The Compression Therapy Market is responding to regulatory and quality standards worldwide by ensuring compliance with FDA (US), CE marking (EU), ISO standards, and national medical device regulations. As the market grows, regulatory oversight is increasingly important for patient safety.

One of the main regulatory considerations is product classification. Compression stockings and bandages are classified as medical devices in most countries, requiring regulatory registration and quality certification. Manufacturers must demonstrate therapeutic effectiveness, safety, and consistent quality control.

The Compression Therapy Market is also adopting international standards such as ISO 13485 for medical device quality management and RAL-GZ 387 for compression stocking quality. These standards ensure consistent compression gradients, durability, and patient safety across products globally.

Post-market surveillance tracks product performance, adverse events, and patient satisfaction. This data feeds back into quality improvements and regulatory compliance, ensuring compression therapy products meet evolving patient and healthcare system needs.

The regulatory-and-quality landscape is explored in market reports, highlighting FDA, CE, ISO requirements, and global compliance trends.

FAQs

Q1: What regulatory bodies oversee compression therapy products?
FDA (US), CE marking (EU), and national medical device authorities regulate compression therapy products requiring registration and quality certification.

Q2: What quality standards apply to compression garments?
Standards include ISO 13485 for medical device quality management and RAL-GZ 387 for compression gradient and durability.

#RegulatoryCompliance #FDA #CEMarking #QualityStandards #CompressionTherapy #MedicalDevices #ISO13485 #ProductSafety #MedicalRegulation #QualityControl